|
Real-time Estimate
Tradegate
14:22:07 19/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 22.06 EUR | -0.20% |
|
+0.71% | +4.63% |
| 11:59am | GSK plc : Deutsche Bank remains Neutral | ZD |
| 08-18 | Chugai grants GSK exclusive global license for AID351 dengue antibody | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,093B | |||||
| 653B | - | - | - | ||
| 458B | |||||
| 355B | |||||
| 294B |
- Stock Market
- Stocks
- GSK Stock
- GS71 Stock
- Charts GSK plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
